Peptipedia
BioregulatorNot FDA ApprovedAnimal Studies

Cartalax

Also known as Ala-Glu-Asp, AED Tripeptide

A synthetic tripeptide designed for joint tissue support and regeneration. Russian studies demonstrate cartilage protective effects.

Available in Russia - Not FDA approved
CompareFind Vendors

Regulatory Pathway

Preclinical
Phase I
Phase II
Phase III
Phase IV
Approved

Dosing Protocol

Typical Dose

10-20 mg daily

Frequency

Per research protocols

Duration

10-30 day courses

Community-reported dosing. Individual results vary. Not a medical recommendation.
Typical community protocol: 10-20 mg daily via Oral (capsules), Per research protocols. Dose range: 10-20 mg daily. Duration: 10-30 day courses.

Timing & Administration

Administer via Oral (capsules). Frequency: Per research protocols.

Mechanism of Action

Regulates gene expression in chondrocytes and cartilage tissue. Promotes cartilage matrix protein synthesis.

Research Summary

Evidence level: animal studies. Clinical status: Available in Russia - Not FDA approved.

Side Effects & Safety

Important Warnings

  • Limited Western validation
  • Not FDA approved.
Generally well-tolerated
mild injection site reactions
transient fatigue
mild GI upset (rare)

References

No references available.

Related Peptides

Browse all →
EpithalonBioregulator

A tetrapeptide studied for its effects on telomerase activation and potential anti-aging properties.

View profile
ThymalinBioregulator

A thymic peptide complex utilized in Russia for immune enhancement and longevity support, developed through Professor Khavinson's bioregulator peptide research.

View profile
PinealonBioregulator

A synthetic tripeptide bioregulator targeting brain tissue, designed to support cognitive function and neuroprotection as part of Khavinson's peptide research.

View profile